How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
Horizon grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.
Stay updated with breaking news from Leland Gershell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Horizon grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.
Operator: Greetings. Welcome to PDS Biotechnology Fourth Quarter 2022 and Full-Year Earnings Conference Call. . A question-and-answer session will follow the formal presentation.
Operator: Good afternoon and welcome to the Trevi Therapeutics Q4 and Year-End 2022 Earnings Conference Call. Please note this event is being recorded.
/PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) –...
Company Representatives: Jan D'Alvise - President, Chief Executive Officer Brian Ford - Chief Financial Officer Pierre Lemieux - Chief Operating and Scientific Officer, Co-Founder Prashant Kohli - Chief...